Dr. Matthew Frieman joins to discuss his expertise, the state of development for treatments outside of vaccines. He takes us through three main categories of development, namely existing drugs, antib...Show More
Ben and Nate discuss interesting new testing procedures, as well as a new FDA authorization for pooled testing. Does it go far enough?
A big news and science roundup including neonatal transmission...Show More
A hard look worldwide at the countries that have done well and poorly overall, and where COVID is changing the most. Plus, evaluating data for hard-hit countries.
A full summary of where we stand o...Show More
Science reporter Denise Grady of the New York Times discusses everything we need to know on vaccines.
The most promising candidates so far.
How mRNA vaccines work.
What steps remain before ca...Show More
Ben does another deep data dive with US case counts and hospitalizations, and a discussion of how those hospitalization numbers will eventually correlate with deaths.
Economic indicators are on the...Show More
Dr. Fauci’s recent podcast appearances discussing vaccine progress and distribution, durability of immune response, and progress on rapid testing technology.
How aerosolized transmission causes sup...Show More
Dr. Talia Swartz of the Icahn School of Medicine at Mount Sinai in New York discusses:
The all hands on deck response at hospitals during the depths of the crisis in New York.
How treatment of s...Show More
We start with a catch-up on the latest US numbers.
California rolls back reopening and LA and SD schools announce no in-person classes.
Wal-Mart joins a growing list of retailers requiring face ...Show More